Metabolic therapy directed at electron transport

This invention relates to a method of treating metabolic derangement, characterized by cellular oxidative dysfunction, in living tissue. More particularly, the invention relates to the administration of a cellular oxidative function altering agent while monitoring cellular oxidative function. The agent is administered until cellular oxidative function is restored. A method of treating metabolic derangement is provided. Specifically, the method comprises the steps of administering an amount of an agent to alter cellular oxidative function while monitoring cellular oxidative function. The administration of the agent may be varied as a function of the monitored cellular oxidative function and will preferably be ceased when cellular oxidative function is restored.